Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Healthcare Triangle (HCTI) EBIT (2020 - 2025)

Historic EBIT for Healthcare Triangle (HCTI) over the last 6 years, with Q3 2025 value amounting to -$2.6 million.

  • Healthcare Triangle's EBIT fell 12202.23% to -$2.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$5.8 million, marking a year-over-year decrease of 392.89%. This contributed to the annual value of -$4.8 million for FY2024, which is 3825.86% up from last year.
  • Latest data reveals that Healthcare Triangle reported EBIT of -$2.6 million as of Q3 2025, which was down 12202.23% from -$1.4 million recorded in Q2 2025.
  • In the past 5 years, Healthcare Triangle's EBIT registered a high of $469000.0 during Q2 2021, and its lowest value of -$10.7 million during Q4 2022.
  • Over the past 5 years, Healthcare Triangle's median EBIT value was -$1.5 million (recorded in 2023), while the average stood at -$2.1 million.
  • Its EBIT has fluctuated over the past 5 years, first crashed by 102519.99% in 2021, then skyrocketed by 8718.72% in 2023.
  • Over the past 5 years, Healthcare Triangle's EBIT (Quarter) stood at -$3.3 million in 2021, then crashed by 219.53% to -$10.7 million in 2022, then soared by 87.19% to -$1.4 million in 2023, then skyrocketed by 63.57% to -$498000.0 in 2024, then crashed by 420.28% to -$2.6 million in 2025.
  • Its EBIT stands at -$2.6 million for Q3 2025, versus -$1.4 million for Q2 2025 and -$1.4 million for Q1 2025.